• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
  • Nowy
Advances in Systemic Therapy for Lung Cancer, An Issue of Thoracic Surgery Clinics

Advances in Systemic Therapy for Lung Cancer, An Issue of Thoracic Surgery Clinics

9780443415135
604,75 zł
514,04 zł Zniżka 90,71 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 514,04 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
In this issue of Thoracic Surgery Clinics, guest editors Drs. Brendon M. Stiles and Tamar B. Nobel bring their considerable expertise to the topic of Advances in Systemic Therapy for Lung Cancer. Recent advances in systemic therapies, marked by ongoing clinical trials and new drug approvals, have revolutionized the treatment landscape, offering new hope for patients with lung cancer. This issue features articles by top experts who explore various topics including novel neoadjuvant and adjuvant clinical trials that could redefine standard care protocols.
Szczegóły produktu
Elsevier
104217
9780443415135
9780443415135

Opis

Rok wydania
2025
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Wymiary (mm)
178 x 254
Waga (g)
450
  • Neoadjuvant Immunotherapy
    Neoadjuvant Chemoimmunotherapy
    Neoadjuvant Tyrosine Kinase Inhibitors
    Surgical Challenges After Neoadjuvant Therapy
    Adjuvant Immunotherapy in Lung Cancer: Foundational Successes and Future Directions
    The Evolving Role of Adjuvant TKI in Lung Cancer: From Historical Trials to Future Strategies National Cancer Center Hospital East, Japan
    Neoadjuvant, Adjuvant, or Both? Optimizing Perioperative Systemic Therapy in Lung Cancer
    Adding Immunotherapy and Targeted Therapy to Chemoradiotherapy for Non-small Cell Lung Cancer
    Update on Neoadjuvant and Adjuvant Trials
    Advances in Systemic Therapy for Lung Cancer: Update on Biomarkers and Novel Drugs for Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC)
    Role of Surgery for Patients with Metastatic Non-small Cell Lung Cancer
Komentarze (0)